MA40444A - Procédé de préparation de formulations de poudre sèche - Google Patents

Procédé de préparation de formulations de poudre sèche

Info

Publication number
MA40444A
MA40444A MA040444A MA40444A MA40444A MA 40444 A MA40444 A MA 40444A MA 040444 A MA040444 A MA 040444A MA 40444 A MA40444 A MA 40444A MA 40444 A MA40444 A MA 40444A
Authority
MA
Morocco
Prior art keywords
preparation
dry powder
powder formulations
formulations
inhalation
Prior art date
Application number
MA040444A
Other languages
English (en)
Inventor
Özlem Akdas
Devrim Celik
Ali Türkyilmaz
Original Assignee
Arven Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret As filed Critical Arven Ilac Sanayi Ve Ticaret As
Publication of MA40444A publication Critical patent/MA40444A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne un nouveau procédé utilisé pour la préparation de formulations de poudre sèche à inhaler.
MA040444A 2014-07-09 2015-07-08 Procédé de préparation de formulations de poudre sèche MA40444A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201408047 2014-07-09

Publications (1)

Publication Number Publication Date
MA40444A true MA40444A (fr) 2017-05-17

Family

ID=52474057

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040444A MA40444A (fr) 2014-07-09 2015-07-08 Procédé de préparation de formulations de poudre sèche

Country Status (6)

Country Link
US (1) US20170143626A1 (fr)
EP (1) EP3166592A1 (fr)
EA (1) EA201692428A1 (fr)
MA (1) MA40444A (fr)
UA (1) UA117534C2 (fr)
WO (1) WO2016005440A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022146254A1 (fr) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Procédé de préparation de compositions en poudre sèche pour inhalation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100912324B1 (ko) 2001-09-14 2009-08-14 글락소 그룹 리미티드 호흡기 질환 치료용 펜에탄올아민 유도체
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
EP2056836A1 (fr) * 2006-08-22 2009-05-13 Boehringer Ingelheim International GmbH Formulations de poudre pour inhalation contenant des bêta-agonistes purs sur le plan énantiomérique
ES2739352T3 (es) * 2009-02-26 2020-01-30 Glaxo Group Ltd Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol

Also Published As

Publication number Publication date
EP3166592A1 (fr) 2017-05-17
US20170143626A1 (en) 2017-05-25
WO2016005440A1 (fr) 2016-01-14
UA117534C2 (uk) 2018-08-10
EA201692428A1 (ru) 2017-03-31

Similar Documents

Publication Publication Date Title
MX2023008686A (es) Polinucleotidos moduladores.
IN2014CH00247A (fr)
EP3107548B8 (fr) Préparations de poudre sèche à inhaler
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
IL248267B (en) A process for preparing converted cycloserines
IN2014CH00840A (fr)
PL3179986T3 (pl) Suche formulacje w proszku do inhalacji
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
MX2016011401A (es) Composiciones farmaceuticas que comprenden levocetirizina.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
NZ721832A (en) Solid forms of tenofovir
MA40444A (fr) Procédé de préparation de formulations de poudre sèche
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
GEP20196944B (en) Process for preparing the inhalation formulations
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MA40443A (fr) Nouveau procédé de préparation de formulations de poudre sèche
TR201818680T4 (tr) İnhalasyona yönelik formülasyonların hazırlanması için bir proses.
MX2016016612A (es) Formulaciones estables de undecanoato de testosterona.
HUP1400518A2 (hu) Eljárás tofacitinib elõállítására
IN2014CH01391A (fr)
IL267198B (en) Process for the preparation of powder preparations
IN2014MU01191A (fr)
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.